Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium Bacteria

NCT00004988 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

NIH

Sponsor class

Conditions

Cancer
Neoplasm
Neoplasm Metastasis

Interventions

DRUG: VNP20009

Sponsor

National Cancer Institute (NCI)